| scholarly article | Q13442814 |
| P50 | author | Paramasivam Prabu | Q59705203 |
| P2093 | author name string | V Mohan | |
| M Balasubramanyam | |||
| K Gokulakrishnan | |||
| S Aravind | |||
| H Ranjani | |||
| C Sathishkumar | |||
| P2860 | cites work | Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathways | Q40485152 |
| Loss of mir-146a function in hormone-refractory prostate cancer | Q42055882 | ||
| Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy | Q42513483 | ||
| Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation | Q43699235 | ||
| Subclinical inflammation/oxidation as revealed by altered gene expression profiles in subjects with impaired glucose tolerance and Type 2 diabetes patients | Q46177953 | ||
| Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection | Q46467772 | ||
| Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes | Q47693425 | ||
| Is type II diabetes mellitus a disease of the innate immune system? | Q48364597 | ||
| Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus. | Q51549607 | ||
| MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. | Q54733079 | ||
| Biomarkers in osteoarthritis | Q58210782 | ||
| Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes | Q59326276 | ||
| Kinetics of calcium transport across the lymphocyte plasma membrane | Q70474025 | ||
| Visfatin, TNF-alpha and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women | Q81479451 | ||
| TRAF6 knockdown promotes survival and inhibits inflammatory response to lipopolysaccharides in rat primary renal proximal tubule cells | Q82805396 | ||
| Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex | Q82858440 | ||
| MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins | Q83586463 | ||
| Inflammation and insulin resistance | Q22241893 | ||
| Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 | ||
| The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway | Q24648295 | ||
| NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses | Q24670080 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta | Q28188643 | ||
| Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES) | Q28200186 | ||
| Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms | Q28586863 | ||
| Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 | ||
| Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB | Q29619314 | ||
| Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance | Q33941406 | ||
| Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma | Q34778280 | ||
| The association between innate immunity gene (IRAK1) and C-reactive protein in the Diabetes Heart Study | Q36015656 | ||
| Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients | Q36955334 | ||
| Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial | Q36975713 | ||
| MicroRNAs: novel regulators in skin inflammation | Q37141220 | ||
| microRNAs and the immune response | Q37178538 | ||
| SNPs in human miRNA genes affect biogenesis and function | Q37344542 | ||
| The expression of TNF alpha by human muscle. Relationship to insulin resistance | Q37352139 | ||
| Expression of microRNA-146 in rheumatoid arthritis synovial tissue | Q37359799 | ||
| Meta-regulation: microRNA regulation of glucose and lipid metabolism | Q37607525 | ||
| Role of NF-kappa B in the pathogenesis of diabetes and its associated complications | Q37611364 | ||
| IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced interleukin-10 gene expression | Q38335828 | ||
| Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial | Q38378882 | ||
| Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. | Q39455009 | ||
| The Chennai Urban Rural Epidemiology Study (CURES)--study design and methodology (urban component) (CURES-I). | Q39673252 | ||
| Suppressors of cytokine signaling abrogate diabetic nephropathy | Q39735007 | ||
| Association of high sensitivity C-reactive protein (hsCRP) and tumour necrosis factor-alpha (TNF-alpha) with carotid intimal medial thickness in subjects with different grades of glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES | Q39838141 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | insulin resistance | Q1053470 |
| type 2 diabetes | Q3025883 | ||
| inflammation | Q101991 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 197-205 | |
| P577 | publication date | 2011-01-20 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes | |
| P478 | volume | 351 |
| Q46922229 | (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus |
| Q37728970 | A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus |
| Q42825832 | Accelerated fat cell aging links oxidative stress and insulin resistance in adipocytes |
| Q42362062 | Acute strength training promotes responses in whole blood circulating levels of miR-146a among older adults with type 2 diabetes mellitus. |
| Q36811697 | Affection of single-nucleotide polymorphisms in miR-27a, miR-124a, and miR-146a on susceptibility to type 2 diabetes mellitus in Chinese Han people |
| Q35895767 | Amelioration of glucolipotoxicity-induced endoplasmic reticulum stress by a "chemical chaperone" in human THP-1 monocytes |
| Q46792665 | Analysis of circulating microRNAs that are specifically increased in hyperlipidemic and/or hyperglycemic sera |
| Q42371220 | Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy |
| Q64232914 | Anti-inflammatory microRNA-146a protects mice from diet-induced metabolic disease |
| Q53281104 | Association of MiR-146a Expression and Type 2 Diabetes Mellitus: A Meta-Analysis. |
| Q36275002 | Association study of polymorphisms in miRNAs with T2DM in Chinese population |
| Q37389836 | Atypical Diabetic Foot Ulcer Keratinocyte Protein Signaling Correlates with Impaired Wound Healing. |
| Q37436828 | Augmentation of histone deacetylase 3 (HDAC3) epigenetic signature at the interface of proinflammation and insulin resistance in patients with type 2 diabetes |
| Q92855414 | Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus? |
| Q40616882 | Circulating cell-free mature microRNAs and their target gene prediction in bovine metritis |
| Q36955787 | Circulating inflamma-miRs in aging and age-related diseases |
| Q39141563 | Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? |
| Q38544077 | Circulating microRNAs and diabetes: potential applications in medical practice. |
| Q53807960 | Circulating microRNAs in Diabetes Progression: Discovery, Validation, and Research Translation. |
| Q34179239 | Circulating microRNAs in patients with non-alcoholic fatty liver disease |
| Q58923865 | Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes |
| Q38760874 | Contribution of MicroRNAs to autoimmune diseases |
| Q34690982 | Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients |
| Q53643581 | Deregulation of NF-кB-miR-146a negative feedback loop may be involved in the pathogenesis of diabetic neuropathy. |
| Q38598866 | Diabetes and ageing-induced vascular inflammation |
| Q38858690 | E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis. |
| Q89999365 | Epigenetic disturbances in obesity and diabetes: Epidemiological and functional insights |
| Q35645997 | Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes |
| Q36242179 | Epithelial cell-derived micro RNA-146a generates interleukin-10-producing monocytes to inhibit nasal allergy |
| Q53520277 | Exosomal MicroRNA-15a Transfer from the Pancreas Augments Diabetic Complications by Inducing Oxidative Stress. |
| Q57300009 | Exosomes Derived From Mesenchymal Stromal Cells Pretreated With Advanced Glycation End Product-Bovine Serum Albumin Inhibit Calcification of Vascular Smooth Muscle Cells |
| Q36001906 | Exposure and fetal growth-associated miRNA alterations in the human placenta |
| Q36806427 | Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene. |
| Q36942373 | High glucose concentration induces endothelial cell proliferation by regulating cyclin-D2-related miR-98. |
| Q34541913 | High-fructose diet is as detrimental as high-fat diet in the induction of insulin resistance and diabetes mediated by hepatic/pancreatic endoplasmic reticulum (ER) stress. |
| Q46773455 | Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies |
| Q95267574 | Impact of Low Interferon-γ and IL-10 Levels on TNF-α and IL-6 Production by PHA-Induced PBMCs in Type 2 Diabetes Mellitus |
| Q92820179 | Impact of mesenchymal stem cell senescence on inflammaging |
| Q51377185 | Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. |
| Q40158529 | Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes |
| Q28536498 | Increased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitus |
| Q91302959 | Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases |
| Q39127898 | Interplay between miRNAs and human diseases |
| Q36205231 | Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms |
| Q34233659 | MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis |
| Q27307894 | MiR-155 Enhances Insulin Sensitivity by Coordinated Regulation of Multiple Genes in Mice |
| Q53842061 | MiR-26b modulates insulin sensitivity in adipocytes by interrupting the PTEN/PI3K/AKT pathway. |
| Q92537678 | MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity |
| Q33654397 | MicroRNA Expression Varies according to Glucose Tolerance, Measurement Platform, and Biological Source |
| Q64074554 | MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies |
| Q58923883 | MicroRNA genetic variations: association with type 2 diabetes |
| Q36890424 | MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms. |
| Q38103446 | MicroRNA in immunity and autoimmunity |
| Q35565357 | MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure |
| Q34266384 | MicroRNA-146a decreases high glucose/thrombin-induced endothelial inflammation by inhibiting NAPDH oxidase 4 expression |
| Q55279635 | MicroRNA-146a: A Comprehensive Indicator of Inflammation and Oxidative Stress Status Induced in the Brain of Chronic T2DM Rats. |
| Q55089831 | MicroRNA-146b-3p regulates the development and progression of cerebral infarction with diabetes through RAF1/P38MAPK/COX-2 signaling pathway. |
| Q27025580 | MicroRNAs Related to Polycystic Ovary Syndrome (PCOS) |
| Q26852909 | MicroRNAs: new insights into chronic childhood diseases |
| Q38780771 | Microparticles of healthy origins improve endothelial progenitor cell dysfunction via microRNA transfer in an atherosclerotic hamster model. |
| Q33911774 | Mother's Pre-pregnancy BMI and Placental Candidate miRNAs: Findings from the ENVIRONAGE Birth Cohort. |
| Q38561971 | Noncoding RNAs and chronic inflammation: Micro-managing the fire within. |
| Q60475996 | Postprandial inflammation is not associated with endoplasmic reticulum stress in peripheral blood mononuclear cells from healthy lean men |
| Q38944060 | Recent progress toward the use of circulating microRNAs as clinical biomarkers |
| Q36209324 | Regulation of Macrophage, Dendritic Cell, and Microglial Phenotype and Function by the SOCS Proteins. |
| Q33815663 | Regulation of retinal inflammation by rhythmic expression of MiR-146a in diabetic retina |
| Q38230799 | Relevance of microRNA in metabolic diseases. |
| Q38899151 | SEAP activity serves for demonstrating ER stress induction by glucolipotoxicity as well as testing ER stress inhibitory potential of therapeutic agents |
| Q37594083 | SIRT4 overexpression protects against diabetic nephropathy by inhibiting podocyte apoptosis |
| Q92645690 | Sequence variation in microRNA-34a is associated with diabetes mellitus susceptibility in a southwest Chinese Han population |
| Q93018504 | Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review |
| Q50796757 | Silencing miR-146a influences B cells and ameliorates experimental autoimmune myasthenia gravis. |
| Q36485126 | Socs1 and Socs3 degrades Traf6 via polyubiquitination in LPS-induced acute necrotizing pancreatitis |
| Q36466672 | Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D. |
| Q38177673 | Suppressors of cytokine signaling (SOCS) and type 2 diabetes |
| Q52661592 | TRAF molecules in inflammation and inflammatory diseases. |
| Q26827627 | The Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound Healing |
| Q90437527 | The association of two common polymorphisms in miRNAs with diabetes mellitus: A meta-analysis |
| Q39152911 | The impact of chronic hepatitis C infection on cholesterol metabolism in PBMCs is associated with microRNA-146a expression |
| Q37512125 | The role of miR-146a in dorsal root ganglia neurons of experimental diabetic peripheral neuropathy |
| Q48147993 | The rs2910164 variant is associated with reduced miR-146a expression but not cytokine levels in patients with type 2 diabetes |
| Q35665925 | Type 2 Diabetes Monocyte MicroRNA and mRNA Expression: Dyslipidemia Associates with Increased Differentiation-Related Genes but Not Inflammatory Activation |
| Q38194186 | Type 2 diabetes mellitus-related genetic polymorphisms in microRNAs and microRNA target sites. |
| Q46004196 | Upregulation of microRNA-146a was not accompanied by downregulation of pro-inflammatory markers in diabetic kidney. |
| Q54267584 | Whole transcriptome analysis reveals differential gene expression profile reflecting macrophage polarization in response to influenza A H5N1 virus infection. |
| Q38784593 | miR-146a Attenuates Inflammatory Pathways Mediated by TLR4/NF-κB and TNFα to Protect Primary Human Retinal Microvascular Endothelial Cells Grown in High Glucose |
| Q93064272 | miR-146a Deficiency Accelerates Hepatic Inflammation Without Influencing Diet-induced Obesity in Mice |
| Q38916732 | miR-146a mediates inflammatory changes and fibrosis in the heart in diabetes. |
| Q89997759 | miR-146a mediates thymosin β4 induced neurovascular remodeling of diabetic peripheral neuropathy in type-II diabetic mice |
| Q53339809 | miR-146a suppresses STAT3/VEGF pathways and reduces apoptosis through IL-6 signaling in primary human retinal microvascular endothelial cells in high glucose conditions. |
| Q43438635 | miR-210 over-expression enhances mesenchymal stem cell survival in an oxidative stress environment through antioxidation and c-Met pathway activation |
| Q38600595 | miRNAs: early prognostic biomarkers for Type 2 diabetes mellitus? |
| Q48562097 | microRNA in Human Reproduction |
| Q34245279 | microRNA regulation of inflammatory responses |
Search more.